<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39018526</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>15</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Discovery of GS-7682, a Novel 4'-Cyano-Modified <i>C</i>-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys.</ArticleTitle><Pagination><StartPage>12945</StartPage><EndPage>12968</EndPage><MedlinePgn>12945-12968</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.4c00899</ELocationID><Abstract><AbstractText>Acute respiratory viral infections, such as pneumovirus and respiratory picornavirus infections, exacerbate disease in COPD and asthma patients. A research program targeting respiratory syncytial virus (RSV) led to the discovery of GS-7682 (<b>1</b>), a novel phosphoramidate prodrug of a 4'-CN-4-aza-7,9-dideazaadenosine <i>C</i>-nucleoside GS-646089 (<b>2</b>) with broad antiviral activity against RSV (EC<sub>50</sub> = 3-46 nM), human metapneumovirus (EC<sub>50</sub> = 210 nM), human rhinovirus (EC<sub>50</sub> = 54-61 nM), and enterovirus (EC<sub>50</sub> = 83-90 nM). Prodrug optimization for cellular potency and lung cell metabolism identified 5'-methyl [(<i>S</i>)-hydroxy(phenoxy)phosphoryl]-l-alaninate in combination with 2',3'-diisobutyrate promoieties as being optimal for high levels of intracellular triphosphate formation <i>in vitro</i> and <i>in vivo</i>. <b>1</b> demonstrated significant reductions of viral loads in the lower respiratory tract of RSV-infected African green monkeys when administered once daily via intratracheal nebulized aerosol. Together, these findings support additional evaluation of <b>1</b> and its analogues as potential therapeutics for pneumo- and picornaviruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siegel</LastName><ForeName>Dustin S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0009-0008-1365-0287</Identifier><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>Hon C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitts</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermillion</LastName><ForeName>Meghan S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lovelace Biomedical, Albuquerque, New Mexico 87108, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishida</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rautiola</LastName><ForeName>Davin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keeney</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irshad</LastName><ForeName>Hammad</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Lovelace Biomedical, Albuquerque, New Mexico 87108, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lijun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Kwon</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Bindu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doerffler</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Michael O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmiotti</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijjapurapu</LastName><ForeName>Arya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riola</LastName><ForeName>Nicholas C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stray</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murakami</LastName><ForeName>Eisuke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yili</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchand</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seung</LastName><ForeName>Minji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nayak</LastName><ForeName>Arabinda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomkinson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadrichu</LastName><ForeName>Nani</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Inspired - Pulmonary Solutions, San Carlos, California 94070, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barauskas</LastName><ForeName>Ona</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Joy Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Jason K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-5492-0652</Identifier><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perron</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilello</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuehl</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-7567-3002</Identifier><AffiliationInfo><Affiliation>Lovelace Biomedical, Albuquerque, New Mexico 87108, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Raju</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cihlar</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackman</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0001-8861-7205</Identifier><AffiliationInfo><Affiliation>Gilead Sciences, Inc., Foster City, California 94404, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011355">Prodrugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011355" MajorTopicYN="Y">Prodrugs</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010849" MajorTopicYN="Y">Picornaviridae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012136" MajorTopicYN="N">Respiratory Syncytial Viruses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="N">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>16</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39018526</ArticleId><ArticleId IdType="doi">10.1021/acs.jmedchem.4c00899</ArticleId></ArticleIdList></PubmedData></PubmedArticle>